HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.

AbstractRATIONALE:
Efficient clearance of apoptotic cells (efferocytosis) is a prerequisite for inflammation resolution and tissue repair. After myocardial infarction, phagocytes are recruited to the heart and promote clearance of dying cardiomyocytes. The molecular mechanisms of efferocytosis of cardiomyocytes and in the myocardium are unknown. The injured heart provides a unique model to examine relationships between efferocytosis and subsequent inflammation resolution, tissue remodeling, and organ function.
OBJECTIVE:
We set out to identify mechanisms of dying cardiomyocyte engulfment by phagocytes and, for the first time, to assess the causal significance of disrupting efferocytosis during myocardial infarction.
METHODS AND RESULTS:
In contrast to other apoptotic cell receptors, macrophage myeloid-epithelial-reproductive tyrosine kinase was necessary and sufficient for efferocytosis of cardiomyocytes ex vivo. In mice, Mertk was specifically induced in Ly6c(LO) myocardial phagocytes after experimental coronary occlusion. Mertk deficiency led to an accumulation of apoptotic cardiomyocytes, independently of changes in noncardiomyocytes, and a reduced index of in vivo efferocytosis. Importantly, suppressed efferocytosis preceded increases in myocardial infarct size and led to delayed inflammation resolution and reduced systolic performance. Reduced cardiac function was reproduced in chimeric mice deficient in bone marrow Mertk; reciprocal transplantation of Mertk(+/+) marrow into Mertk(-/-) mice corrected systolic dysfunction. Interestingly, an inactivated form of myeloid-epithelial-reproductive tyrosine kinase, known as solMER, was identified in infarcted myocardium, implicating a natural mechanism of myeloid-epithelial-reproductive tyrosine kinase inactivation after myocardial infarction.
CONCLUSIONS:
These data collectively and directly link efferocytosis to wound healing in the heart and identify Mertk as a significant link between acute inflammation resolution and organ function.
AuthorsElaine Wan, Xin Yi Yeap, Shirley Dehn, Rachael Terry, Margaret Novak, Shuang Zhang, Shinichi Iwata, Xiaoqiang Han, Shunichi Homma, Konstantinos Drosatos, Jon Lomasney, David M Engman, Stephen D Miller, Douglas E Vaughan, John P Morrow, Raj Kishore, Edward B Thorp
JournalCirculation research (Circ Res) Vol. 113 Issue 8 Pg. 1004-12 (Sep 27 2013) ISSN: 1524-4571 [Electronic] United States
PMID23836795 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Ly
  • CD36 Antigens
  • Ly-6C antigen, mouse
  • Proto-Oncogene Proteins
  • Mertk protein, mouse
  • Receptor Protein-Tyrosine Kinases
  • c-Mer Tyrosine Kinase
Topics
  • Animals
  • Antigens, Ly (metabolism)
  • Apoptosis
  • Bone Marrow Transplantation
  • CD36 Antigens (deficiency, genetics)
  • Cells, Cultured
  • Coculture Techniques
  • Disease Models, Animal
  • Female
  • Inflammation (enzymology, genetics, immunology, pathology)
  • Macrophages (enzymology, immunology, pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myocardial Contraction
  • Myocardial Infarction (enzymology, genetics, immunology, pathology, physiopathology)
  • Myocytes, Cardiac (enzymology, immunology, pathology)
  • Phagocytosis
  • Proto-Oncogene Proteins (deficiency, genetics, metabolism)
  • Receptor Protein-Tyrosine Kinases (deficiency, genetics, metabolism)
  • Recovery of Function
  • Signal Transduction
  • Time Factors
  • Transplantation Chimera
  • Ventricular Function, Left
  • Ventricular Remodeling
  • Wound Healing
  • c-Mer Tyrosine Kinase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: